5-alpha Reductase and Active Surveillance

May 18, 2012  

5-alpha Reductase Inhibitors Help Prostate Cancer Patients on Active Surveillance

Jill Stein
Published Online: Monday, May 14, 2012
With reference to Antonio Finelli, MD, University Health Network, Princess Margaret Hospital
Click here to view article.

New Therapies

May 18, 2012  

New Therapies for Prostate Cancer: The Practicalities
Jeannette Y. Wick, RPh, MBA
Published Online: Tuesday, May 15, 2012

Click here to view article.

Management of Metastatic Castration-resistant Prostate Cancer

February 3, 2012  

Management of Metastatic Castration-resistant Prostate Cancer
Abstract

The management of men with metastatic castration-resistant prostate cancer (CRPC) has taken several leaps forwards in the last two years, with the demonstration of improved overall survival with three novel agents (sipuleucel-T, cabazitaxel and abiraterone acetate) and a significant delay in skeletal-related events observed with denosumab.

Click here for more.

Dutasteride in localised prostate cancer management

February 1, 2012  

Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial

Interpretation

Dutasteride could provide a beneficial adjunct to active surveillance for men with low-risk prostate cancer.

Click here for full article.

Extending Lives of Men With Prostate Cancer

February 1, 2012  

Advanced prostate cancer patients live longer with MDV3100

Reviewed By: Joseph V. Madia, MD [www.dailyrx.com]
By: Laurie Stoneham [www.dailyrx.com]
Published:  Jan 31, 2012 04:17 pm

Click here to see article.

Brachytherapy for High-Risk Patients

January 27, 2012  

ScienceDaily (Jan. 25, 2012) — Brachytherapy for high-risk prostate cancers patients has historically been considered a less effective modality, but a new study from radiation oncologists at the Kimmel Cancer Center at Jefferson suggests otherwise.

Read more.

Focal Therapy

January 17, 2012  

Dr. Uri Lindner, a medical associate of Dr. Trachtenberg at PMH, will be our guest speaker at our 25 July 2012 Awareness Night at Toronto Botanical Gardens. His topic will be Focal Therapy.  Click here for more information on Focal Therapy.

Dr. Myers talks about active surveillance versus watchful waiting for prostate cancer

December 20, 2011  

Dr. Myers compares active surveillance and watchful waiting for prostate cancer in this 6:51 video. Click here to view.

VIDEO: Introduction To Brachytherapy

December 10, 2011  

Dr. Saibishkumar Elantholi Parameswaran  (Dr. Saibish)

Radiation Oncologist, Princess Margaret Hospital/University Health Network, Toronto Canada
Assistant Professor, Department of Radiation Oncology, University of Toronto

Dr. Saibish uses this video at Princess Margaret Hospital to familiarize his patients with Brachytherapy. There is information on Prostate Cancer, as well.

12 minutes